Poster: IBCL-460 Subcutaneous Epcoritamab With Rituximab + Lenalidomide (R2) in Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Update from Phase 1/2 Trial

Subjects

Subjects :

Cancer Research
Oncology
Hematology

Details

ISSN :

21522650

Volume :

22

Database :

OpenAIRE

Journal :

Clinical Lymphoma Myeloma and Leukemia

Accession number :

edsair.doi...........25f41e8533a0a349ee58d659f7d5deb9